Less Ads, More Data, More Tools Register for FREE

Pin to quick picksYGEN.L Regulatory News (YGEN)

  • There is currently no data for YGEN

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

QuantumRD Services in China

1 Oct 2012 07:00

RNS Number : 5302N
ViaLogy PLC
01 October 2012
 



ViaLogy to Offer QuantumRD Services in China

 

 

London, UK October 1, 2012. ViaLogy PLC(LSE/AIM: VIY) announces that the company is in exploratory discussions with some of the largest Chinese national oil companies (NOCs) and upstream services providers to deploy QuantumRD® software platform for both their national and global assets.

 

As the world's 4th largest producer, China possesses substantial energy resources that include over 20 billion barrels of oil (14th largest in the world) and 100Tcf of natural gas. China's increasing energy needs coupled with growing emphasis on new discoveries, optimizing primary recovery efficiencies, and cost-effective development of proven fields provide a major opportunity for leveraging QuantumRD capabilities.

 

Some of the key strategic initiatives for Chinese operators include increasing production from mature fields; exploring new offshore areas of Bohai Bay and the South China Sea as well as onshore oil in western interior provinces such as Xinjiang and Inner Mongolia. QuantumRD processing to discover and characterize thin laminates, and delineate reservoirs below seismic resolution in complex tectonic stratigraphy using existing 3-D are seen as particularly attractive to support ongoing programs.

 

ViaLogy is discussing service delivery arrangements whereby QuantumRDsoftware platform can be utilized to determine the locations of new hydrocarbon assets on active fields. QuantumRD®can potentially provide more accurate structural and stratigraphic interpretations of seismic data than is now achievable with industry-standard tools. ViaLogy's software platform broadens the useable seismic spectra for both low and high frequencies, thus extracting porosity, lithology and fluid information from weak signal data normally discarded because it is buried in background noise and is unrecoverable. The technique is a major departure from current industry capabilities in reservoir characterization, and holds the promise of major cost avoidance and discovery of reserves otherwise undetected to increase the success rate of exploratory drilling and hydrocarbon recovery.

 

These business discussions follow issuance of a patent in China for QRI® related technology, which provides the fundamental weak signal processing and computational engine (employing quantum resonance interferometry) for ViaLogy's QuantumRD software platform. The company currently has a number of QuantumRD related patents pending in China.

ViaLogy CEO Robert Dean said, "We are excited by the possibility of applying QuantumRD technology on Chinese prospects, by the business value we could bring to their ongoing exploration and development efforts, and extending their de-risking toolkit for a wide range of conventional and non-conventional formations. We hope to provide the same increases in seismic resolution that we have shown to date with carbonate and sandstone reservoirs in the US and our offshore work in Asia."

Dean added, "We are currently in discussions with potential partners to find the best working structures and business models."

 

For further information contact: 

ViaLogy

Terry Bond, Chairman - UK & Europe +44 (0) 1235-834734

Nominated Advisor to ViaLogy PLC (Seymour Pierce)

Mark Percy/Catherine Leftley, Corporate Finance +44 (0) 20-7107-8000

Katie Ratner Corporate Broking +44 (0) 20-7107-8000

 

About ViaLogy:

ViaLogy provides reservoir characterization, geophysical imaging and hydrocarbon sizing services to global oil and gas customers based on proprietary, patented active signal processing technology. ViaLogy's QuantumRD® platform assists clients in de-risking prospects over a broad range of subsurface lithologies and complex stratigraphies to generate drilling targets, position offsets and enhance recovery. ViaLogy's core technology rapidly and accurately detects weak signals buried in high noise background and clutter, and is applicable to active/passive seismic, electromagnetic and magneto telluric data. By exploiting normally disregarded noise variations induced by changes in porosity, fluid presence and permeability across the formation, and adding computer-designed noise to the data, ViaLogy is able to amplify subtle noise variations to enhance areal and depth resolution in complex lithologies that are not achievable through conventional means. For more information on ViaLogy, visit www.vialogy.com.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCWGUBABUPPGMU
Date   Source Headline
25th Jan 20237:00 amRNSDirectorate Change
18th Jan 202312:07 pmRNSDirector/PDMR Shareholding
17th Jan 202312:06 pmRNSHolding(s) in Company
13th Jan 20234:27 pmRNSDirector/PDMR Shareholding
13th Jan 20231:03 pmRNSHolding(s) in Company
12th Jan 20233:48 pmRNSHolding(s) in Company
12th Jan 20232:43 pmRNSHolding(s) in Company
11th Jan 202312:23 pmRNSHolding(s) in Company
11th Jan 202311:29 amRNSHolding(s) in Company
11th Jan 202311:26 amRNSDirector/PDMR Shareholding
9th Jan 20235:25 pmRNSResult of General Meeting and Retail Offer
6th Jan 20234:35 pmRNSClose of Retail Offer
6th Jan 20233:34 pmRNSHolding(s) in Company
29th Dec 20227:00 amRNSDirector/PDMR Shareholding
23rd Dec 20221:09 pmRNSDirector/PDMR Shareholding
23rd Dec 202211:29 amRNSHolding(s) in Company
23rd Dec 20227:00 amRNSPosting of Circular and Notice of General Meeting
22nd Dec 202211:00 amRNSRetail Offer
22nd Dec 20227:00 amRNSResult of Placing and Subscriptions
21st Dec 20222:29 pmRNSProposed Capital Raising
21st Dec 20222:25 pmRNSHalf-year Report
25th Nov 202211:00 amRNSPrice Monitoring Extension
3rd Nov 20227:00 amRNSFirst half trading update
27th Sep 20223:08 pmRNSResult of AGM
27th Sep 20227:00 amRNSAGM Statement
25th Aug 20227:00 amRNSNotice of AGM & Change of Registered Address
16th Aug 20227:00 amRNSOpen Day and advance notice of AGM
27th Jul 20227:00 amRNSAudited Final Results
27th Jul 20227:00 amRNSDr John Brown CBE confirmed as Chairman
11th Jul 20227:00 amRNSNotice of Final Results
24th May 20227:00 amRNSAccelerator Phase Launch for Microdeletions Plugin
12th May 202211:06 amRNSSecond Price Monitoring Extn
12th May 202211:00 amRNSPrice Monitoring Extension
12th May 20227:00 amRNSCEO share purchase
26th Apr 20227:01 amRNSDirectorate Change
26th Apr 20227:00 amRNSFull year trading update
25th Apr 20227:00 amRNSStrategic partnership extended with Ambry Genetics
12th Apr 20227:00 amRNSIssue of share options and total voting rights
6th Apr 20227:00 amRNSCapital Markets Day
21st Mar 20224:23 pmRNSDirector/PDMR Shareholding
17th Feb 20227:00 amRNSSuccessful CTDA desktop review
25th Jan 20227:00 amRNSDirectorate Change
24th Jan 20227:00 amRNSDirector Dealing
21st Jan 20222:48 pmRNSIssue of Equity & Total Voting Rights
19th Jan 20227:00 amRNSOpening of new Yourgene Health Canada facilities
19th Jan 20227:00 amRNSAgreement of new debt facility
18th Jan 20227:00 amRNSUS partnership with EKF for NIPT and genomic tests
17th Jan 20227:00 amRNSCurrent year trading update
23rd Dec 20217:00 amRNSDHSC contract award for COVID Winter surge testing
14th Dec 202111:00 amRNSUKHSA contract award

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.